2 completed, 1 terminated. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
| Phase 1 | 1 | Completed 1 |
Follow Extra-Adrenal Paraganglioma: new trials by email Literature Review of Extra-Adrenal Paraganglioma trials Research Report on Extra-Adrenal Paraganglioma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pazopanib Hydrochloride in Treating Patients With Advanced or Progressive Malignant Pheochromocytoma or Paraganglioma Laboratory Biomarker Analysis, Pazopanib Hydrochloride - Extra-Adrenal Paraganglioma, Metastatic Adrenal Gland Pheochromocytoma | Phase 2 | Terminated | National Cancer Institute (NCI) | 7 | 2011-05-01 | 2017-09-21 |
| Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors vorinostat, temozolomide, diagnostic laboratory biomarker analysis - Childhood Atypical Teratoid/Rhabdoid Tumor, Childhood Central Nervous System Choriocarcinoma | Phase 1 | Completed | National Cancer Institute (NCI) | 27 | 2010-02-01 | 2013-05-03 |
| RAD001 in Pheochromocytoma or Nonfunctioning Carcinoid RAD001 - Pheochromocytoma, Extra-adrenal Paraganglioma | Phase 2 | Completed | Seoul National University Hospital | 33 | 2008-07-01 | 2015-05-20 |
Paraganglioma, Extra-Adrenal (3) · Pheochromocytoma (2) · Astrocytoma (1) · Choroid Plexus Neoplasms (1) · Familial ependymoma (1) · Medulloblastoma (1) · Oligodendroglioma (1) · Optic Nerve Glioma (1) · Paraganglioma (1) · Rhabdoid Tumor (1) · Spinal Cord Neoplasms (1)
Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms, Germ Cell and Embryonal (3) · Neoplasms, Nerve Tissue (3) · Neuroectodermal Tumors (3) · Neuroendocrine Tumors (3) · Paraganglioma (2) · Brain Diseases (1) · Brain Neoplasms (1) · Central Nervous System Diseases (1) · Central Nervous System Neoplasms (1) · Cerebral Ventricle Neoplasms (1) · Cranial Nerve Diseases (1) · Cranial Nerve Neoplasms (1) · Eye Diseases (1)
Everolimus (1) · Temozolomide (1) · Vorinostat (1) · pazopanib (1)
National Cancer Institute (NCI) (2) · Seoul National University Hospital (1)
United States (2) · Canada (1) · Hong Kong (1) · Singapore (1) · South Korea (1)
Do-Youn Oh, MD, PhD (1) · Keith Bible (1) · Trent Hummel (1) · Yung-Jue Bang, MD, PhD (1)
N01CM00039 (1), N01CM00099 (1), N01CM62205 (1), P30CA015083 (1), U01CA097452 (1)